Raloxifene for Prevention of Osteoporotic Fractures

MOspace/Manakin Repository

Breadcrumbs Navigation

Raloxifene for Prevention of Osteoporotic Fractures

Please use this identifier to cite or link to this item: http://hdl.handle.net/10355/3950

[+] show full item record


Title: Raloxifene for Prevention of Osteoporotic Fractures
Author: Diehr, Sabina; Mijal, Sara; Nashelsky, Joan
Keywords: bone resorption
nonvertebral fractures
menopause
breast cancer
Date: 2005-07
Publisher: Family Physicians Inquiries Network
Citation: American Family Physician, 72(1) 2005.
Abstract: Raloxifene (60 mg daily for three years) will prevent one vertebral fracture, including asymptomatic fractures, for every 46 postmenopausal women with osteoporosis or presence of previous vertebral fractures. Raloxifene has not been shown to prevent nonvertebral fractures. It is unclear if longer duration of treatment is warranted, or whether this risk reduction is sustained after discontinuation of treatment. [Strength of recommendation: A, based on systematic reviews of randomized controlled trials (RCTs)]
URI: http://hdl.handle.net/10355/3950

This item appears in the following Collection(s)

[+] show full item record